Dose-dense chemotherapy for primary breast cancer-Reference-Cited by-同舟云学术

Dose-dense chemotherapy for primary breast cancer

Published:2007-02 Issue:1 Volume:19 Page:75-81
ISSN:1040-872X
Container-title:Current Opinion in Obstetrics & Gynecology
language:en
Short-container-title:

Author:

Kümmel Sherko,Rezai Mahdi,Kimmig Rainer,Schmid Peter

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Obstetrics and Gynecology

Reference17 articles.

1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.;Lancet,2005

2. Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005;Goldhirsch;Ann Oncol,2005

3. Experimental evaluation of potential anticancer agents XIII: On the criteria and kinetics associated with ‘curability’ of experimental leukemia;Skipper;Cancer Chemother Rep,1964

4. Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer;Henderson;J Clin Oncol,2003

5. Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B22;Fisher;J Clin Oncol,1997

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial;Radiotherapy and Oncology;2020-01

2. Updated Survival Analysis after a Median Follow-up of 12 Years of an Anthracycline-Containing Adjuvant Prospective Multicentre, Randomised Phase III Trial on Dose-Dense Chemotherapy in Primary Node-Positive, High-Risk Breast Cancer Patients;Breast Care;2018-09-05

3. Invasive Breast Cancer Therapy 2017: How Well Are We Hitting the Target?;Resistance to Targeted Anti-Cancer Therapeutics;2017

4. A pilot study: dose adaptation of capecitabine using mobile phone toxicity monitoring — supporting patients in their homes;Supportive Care in Cancer;2014-04-26

5. Dose-Dense Chemotherapy in Nonmetastatic Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials;JNCI Journal of the National Cancer Institute;2010-11-23